Public-registry site landscape for NCT01926587, a Myelodysplastic Syndrome study sponsored by Traws Pharma, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT01926587 (registry record) |
| Sponsor | Traws Pharma, Inc. |
| Condition(s) | Myelodysplastic Syndrome; Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 13 |
| Site countries | United States, France |
Eichor generates a preliminary site-risk snapshot for NCT01926587 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →